Based on the findings, GLP-1 medications may benefit the cardiovascular and renal systems while also promoting weight loss, glycemic management, neurocognition, gut function, liver inflammation, alcohol use, and suicidal ideation
In the right patient, it may help support a brighter, more even-looking complexion gradually
Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May WS, Sporn MB, Andreeff M
Small molecules known as glucokinase activators (GKAs) have been developed that enhance the enzymatic activity of glucokinase
Mild nausea, reduced appetite, feeling full quickly, and some fatigue are all normal first-week symptoms that don't require immediate medical attention
Food and Drug Administration first approved to control blood sugar levels in Type 2 diabetes patients in 2005